BSX Looks 55.4% Undervalued on GF Value™ Amid Device Recall Concerns

gurufocus.com · 2026-08-26

On August 26, 2026, Boston Scientific Corp (NYSE: BSX) disclosed a voluntary recall of certain percutaneous catheter devices, including the ENROUTE Transcarotid

Read the full story at gurufocus.com →